Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

China to Grant India Greater Access to its Pharma Market

publication date: Aug 27, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China agreed to give India greater access to its markets for pharma, agriculture and IT products. India has been upset with China because only $18 billion of products flows from India to China, while $57 billion of China products found its way to India over the past 12 months. Most of India’s trade deficit derives from its relationship with China. For its part, China is fretting about a 21% customs duty – done as a warning to China – that India has levied on China power equipment. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
ChinaBio® Events

ChinaBio® Investor Forum
2013-Shanhai
September 4-5,2013
Shanghai, China


ChinaBio® Leadership Retraet
2013-Suzhou
October 24-25, 2013
Suzhou, China


ChinaBio® Investor Forum
2013-Wuhan
December 4-5,2013
Wuhan, China
>>More events...
Partner Events

China Medical Affairs Summit
  June 18-19, 2013
Shanghai, China


China Forum 2013
November 3, 2013
Vienna, Austria

>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners